Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

Franklin Genomic Advancements ETF

This ETF provides exposure to Other Global Equities

HELX performance and flow charts

Last update 4/24/2026 at 7:59 PM
Live
Closed
Last price
$33.52
+$0.11 (+0.32%) today

Performance

-20246810%Mar 24Mar 31Apr 8Apr 15Apr 22

Flows

0
1 day price range
$33.53
$33.53
52 week price range
$25.63
$38.07
1W perf
-3.68%
YTD perf
-7.69%
YTD flows
+$2M
AuM
$22M
E/R
0.5%
TTM yield
-
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of April 24, 2026
1M3MYTD1Y3Y5Y
Perf.+5.41%-10.90%-7.69%+23.56%+9.47%-30.03%
Flows--+$2M+$8M+$9M+$14M
Data as of April 24, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Management strategyActive
StrategyLong Only
ProviderFranklin Templeton
N° of holdings60
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateFebruary 25, 2020
ESGNo
TrackinsightTrackinsight

More data and info about HELX on Trackinsight

Exposure

Data as of March 31, 2026

Diversification

60.42%

Total weight of top 15 holdings out of 60

Top 15 Holdings

NATERA
6.89%
GUARDANT HEALTH INC
6.82%
KRYSTAL BIOTECH INC
5.46%
UTD THERAPEUT
4.4%
BRIDGEBIO PHARMA
4.36%
INSMED
4.31%
LIGAND PHARMACEUTICALS
3.8%
SAMSUNG BIOLOGICS CO LTD
3.37%
ADAPTIVE BIOTECHNOLOGIES
3.32%
ASTRAZENECA
3.24%
VERTEX PHARMACEUTICALS
3.2%
MEDPACE HOLDINGS INC
3.05%
CORTEVA INC
2.81%
ALNYLAM PHARMACEUTICALS
2.71%
REGENERON PHARMACEUTICALS
2.67%

Sectors

Health Care
89.74%
Other
10.26%

Countries

USA
87.6%
Other
12.4%
Advertisement

Trading data

Last sale
4/24/2026 at 7:59 PM
$33.52
Previous close
$33.42
Consolidated volume
04/24/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+24.83%+20.80%+20.28%+23.68%
Max drawdown
-16.86%-17.89%-29.16%-58.50%
Max drawdown duration
88d145d458d1690d
Time to recover
N/AN/A193dN/A
Advertisement
Frequently asked questions about HELX

What type of ETF is HELX?

HELX is a Active ETF that provides exposure to Equity assets. It is managed by Franklin Templeton.

What does HELX invest in?

This ETF provides exposure to Other Global Equities. It is part of the segment: BioTech & Genomics.

What is the expense ratio of HELX?

The total expense ratio (TER) of HELX is 0.5%, representing the annual fee charged by the fund manager.

When was HELX launched?

HELX was launched on February 25, 2020, marking its entry into the ETF market.

Who is the issuer of HELX?

HELX is issued by Franklin Templeton.

What is the AUM of HELX?

As of April 24, 2026, HELX manages $21.77 M, reflecting the total assets held in the fund.

How has HELX performed recently?

As of April 24, 2026, HELX delivered a return of 5.41% over the past month (1M performance), -10.9% over the past three months (3M), and -7.69% year-to-date (YTD).

How many holdings are in HELX

As of March 31, 2026, HELX holds 60 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is HELX?

As of March 31, 2026, HELX holds 60 securities, with 60.42% of its assets concentrated in its top 15 holdings.

What are the top holdings of HELX?

As of March 31, 2026, HELX holds a portfolio of 60 underlyings, with its largest positions including NATERA, GUARDANT HEALTH INC and KRYSTAL BIOTECH INC. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does HELX invest in?

As of March 31, 2026, HELX has its largest geographic exposures in USA.

What sectors or themes does HELX focus on?

As of March 31, 2026, HELX is primarily exposed to Health Care.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Asset TV

The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs

Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

Asset TV
By Asset TV · April 22, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs April 20, 2026

The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Tidal
By Tidal · April 22, 2026
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile

Asset TV

The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile

Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.

Asset TV
By Asset TV · April 15, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs March 30, 2026

The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.

Tidal
By Tidal · March 31, 2026

Browse all educational columns

Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up